Key facts
- It has raised $5.8M; the latest was Seed Round ($5.3M) in Dec 2025.
- Notable investors include Y Combinator, General Catalyst, Collaborative Fund, Initialized Capital, Overwater Ventures — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Feanix Biotechnologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Feanix Biotechnologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Feanix Biotechnologies
Developer of a breeding advising platform designed to offer efficient and sustainable agriculture. The company's platform utilizes proprietary genetic testing and machine learning to simplify optimal breeding decisions by analyzing parent genetics to identify the ideal match for each cow and facilitate successful pregnancies, enabling farmers to minimize wasted pregnancies, create healthy and productive cows, while focusing on growing their business.
- Sector
- Materials and Resources
- HQ
- Asheville, NC, United States
- Founded
- 2021
- Employees
- 10
- Website
- feanixbio.com/
- Ownership
- Privately Held (backing)
Feanix Biotechnologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Feanix Biotechnologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Feanix Biotechnologies in its N-PORT filings yet. We sweep new filings monthly.